Enzo Life Sciences, Inc. v. Roche Molecular Systems, Inc., No. 17-2498 (Fed. Cir. June 20, 2019)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Enzo Life Sciences, Inc. (“Enzo”) appeals the decision of the U.S. District Court for the District of Delaware granting summary judgment against Enzo and holding that the asserted claims are invalid for lack of enablement. ENZO LIFE SCIENCES, INC. V. ROCHE MOLECULAR SYSTEMS, INC. 3 We affirm as to non-enablement and do not reach the other issues presented on appeal. I Deoxyribonucleic acid (“ DNA”) and ribonucleic acid (“RNA”) are nucleic acids. They are made of a series of building blocks, called nucleotides, linked together in a chain.